Stocks
Editas Medicine (EDIT) R&D US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 96.9 | 158.0 | 142.5 | 175.0 | 171.6 | 150.6 | |||
| Changes by years, y/y, % | +7% | +63% | -10% | +23% | -2% | +13.6% | |||
Editas Medicine. R&D, bln rub
Editas Medicine. R&D, changes, %
Editas Medicine. R&D, sum by quarters, bln rub
Editas Medicine (EDIT) R&D US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D, bln rub | 37.8 | 29.8 | 5.34 | 68.1 | 47.4 | 150.6 | ||
| Changes by years, y/y, % | 0% | -32% | -87% | +31% | +25% | |||
| Changes by quarters, q/q, % | -27% | -21% | -82% | +1 176% | -30% | |||
